9-aminocamptothecin by 72-hour continuous intravenous infusion is Inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma
Open Access
- 1 November 1997
- Vol. 80 (9) , 1727-1732
- https://doi.org/10.1002/(sici)1097-0142(19971101)80:9<1727::aid-cncr5>3.0.co;2-b
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.Journal of Clinical Oncology, 1996
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.Journal of Clinical Oncology, 1995
- Surgical options in the treatment of hepatic metastasis from colorectal cancerCurrent Problems in Surgery, 1995
- Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final ReportAnnals of Internal Medicine, 1995
- Rifabutin Prophylaxis against Mycobacterium avium Complex InfectionNew England Journal of Medicine, 1994
- The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.Journal of Clinical Oncology, 1993
- Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.Journal of Clinical Oncology, 1993
- On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complexBiochemistry, 1989
- Efficacy of adjuvant fluorouracil and folinic acid in colon cancer: International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigatorsPublished by Elsevier